MThera Pharma Co., Ltd. is a biopharmaceutical company focused on developing novel multi-component/multi-target driven, disease-modifying therapies for chronic incurable diseases.
MThera has established platform technology, SyMthomics consists of MThera-CODA system (AI based in silico system), the most cutting-edge multi-omics integration technology, systems biology and bioinformatics.
MThera has set up standardization technology & advanced CMC technology for raw materials, drug substances and drug products to meet the US FDA requirement for therapeutic consistency and totality of the evidence.
MThera is pioneering first-in-class botanical drug products to deal with diverse etiology and treat chronic incurable diseases like Parkinson's disease and Inflammatory bowel disease.
Company Details
- Employees
- 7
- Founded
- 2020
- Address
- 38, Magokjungang 8-Ro 1-Gil, Gangseo-Gu, Seoul,07793,korea, Republic Of
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.mtherapharma.com/
- Keywords
- Botanical drug and Pharmaceuticals.
- HQ
- Seoul
Mthera Pharma Questions
Mthera Pharma's website is http://www.mtherapharma.com/
Mthera Pharma's LinkedIn profile is https://kr.linkedin.com/company/mtherapharma
Mthera Pharma has
7 employees.
View email and phone details for 7
employees at Mthera Pharma.
Mthera Pharma's industry is
Pharmaceutical Manufacturing
Mthera Pharma's top competitors are
Sri Upasana Management Consultants Private Limited,
Stgen Bio,
Sml Meditree,
Merlin Med South Africa,
Executive Scouters,
Pharmawest Consulting,
Shaj Pharma Ltd,
Springs Project,
Curocell,
Belab Services - International Regulatory Experts.
Mthera Pharma's categories are Pharmaceutical Manufacturing
Mthera Pharma's founding year is 2020
